EGFR and inflammatory breast carcinoma: In the past few years, new evidence has emerged that EGFR is specifically important for IBC, as EGFR is overexpressed and is a predictor of poor prognosis and worse overall survival and risk of recurrence in this aggressive form of breast cancer [9,10].